Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 38,126 | 0.1% | 84,096 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 26,507 | 0.0% | 67,683 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 27,695 | 0.0% | 62,209 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 19,936 | 0.0% | 41,121 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 52,514 | 0.1% | 130,405 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 21,416 | 0.0% | 46,048 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 37,300 | 0.1% | 79,578 | 6/30/2024 |
| 2024 Q1 | 5/7/2024 | 39,703 | 0.1% | 94,980 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 51,221 | 0.1% | 125,884 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 69,285 | 0.1% | 199,244 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 61,333 | 0.1% | 174,286 | 6/30/2023 |
| 2023 Q1 | 5/16/2023 | 77,303 | 0.1% | 245,353 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 80,570 | 0.2% | 279,001 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 13,418 | 0.0% | 46,343 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 30,467 | 0.1% | 108,121 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 26,842 | 0.0% | 102,853 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 73,857 | 0.1% | 336,325 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 99,806 | 0.1% | 550,229 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 101,530 | 0.1% | 503,547 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 107,201 | 0.1% | 498,866 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 59,492 | 0.1% | 251,720 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 5,326 | 0.0% | 19,573 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 43,057 | 0.1% | 148,312 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 16,738 | 0.0% | 70,341 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 25,772 | 0.1% | 117,705 | 12/31/2019 |
| 2014 Q1 | 5/14/2014 | 12,059 | 0.0% | 170,510 | 3/31/2014 |
| 2013 Q4 | 2/13/2014 | 37,555 | 0.1% | 505,450 | 12/31/2013 |